DGUOK and neoplasm: To determine whether DGUOK targeting could prevent tumor initiation, we used a Tet‐On CRISPR/Cas9 system, where doxycycline treatment could efficiently induce the expression of Cas9 and the depletion of DGUOK protein levels in approximately 1 week (Fig 7E).